Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
Clinical trial NCT05720988 · WITHDRAWN
Trial details
- NCT number
- NCT05720988
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-03
- Primary completion
- 2025-08-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.